ArticleHaematologica2025

Prognostic value of minimal residual disease detected by EuroFlow next-generation flow cytometry and next-generation sequencing in patients with multiple myeloma achieving complete response and receiving lenalidomide maintenance after autotransplant: a prospective comparison study.

Takeshi Yoroidaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.